Cost-Effectiveness of Induction Treatment with Bortezomib Added to Thalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation in Germany
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.498
https://www.valueinhealthjournal.com/article/S1098-3015(13)02403-0/fulltext
Title :
Cost-Effectiveness of Induction Treatment with Bortezomib Added to Thalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation in Germany
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02403-0&doi=10.1016/j.jval.2013.08.498
First page :
A409
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
475